Projected Spending on Psychotropic Medications 2013–2020

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Administration and Policy in Mental Health and Mental Health Services Research

• Publication date

  2016-06-30

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1007/s10488-015-0661-xPMID 26041078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Table (1)

  2016cited by this paper
• National estimates of behavioral health conditions and their treatment among adults newly insured under the ACA.

  2015cited by this paper
• The diminished pipeline for medications to treat mental health and substance use disorders.

  2014cited by this paper
• Spending on mental and substance use disorders projected to grow more slowly than all health spending through 2020.

  2014influential reference
• Re: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program

  2014cited by this paper
• Federal spending on behavioral health accelerated during recession as individuals lost employer insurance.

  2013influential reference
• National health expenditure projections, 2012-22: slow growth until coverage expands and economy improves.

  2013cited by this paper
• National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration.

  2013cited by this paper
• Comment on "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity"

  2013cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• Is There Anything Really Novel on the Antidepressant Horizon?

  2012cited by this paper
• Treating impaired cognition in schizophrenia.

  2012cited by this paper
• An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008.

  2012cited by this paper
• Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

  2012cited by this paper
• Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation

  2010cited by this paper
• Dual eligibles with mental disorders and Medicare part D: how are they faring?

  2009cited by this paper
• Drug patent live and generic competition: Analysis of new molecular entities approved by the FDA between 1980 and 1999

  2008cited by this paper
• Mental Health and Substance Abuse Treatment Prescription Drugs: Lessons From a Period of High Spending Growth

  2006cited by this paper
• Generic Competition in the US Pharmaceutical Industry

  2006cited by this paper
• MARKETWATCH: Listening to generic prozac: Winners, losers, and sideliners

  2004cited by this paper

• Effect of Physical Activity on Drug Expenditures for the Physical and Mental Health of Primary Care Users.

  2026cites this paper
• Projections of Public Spending on Pharmaceuticals: A Review of Methods

  2025cites this paper
• Examining Psychologist Prescriptive Authority as a Cost-Effective Strategy for Reducing Suicide Rates.

  2023cites this paper
• The Association of Outdoor Walking Per Week with Mental Health and Costs of Psychotropic Drugs in Adults

  2022cites this paper
• Estimating Contributions of Social and Behavioral Factors to Cardiovascular Disease, Cancer, COPD, and Unintentional-Injury Mortality Disparities by Psychological Distress in the United States: A Blinder-Oaxaca Decomposition Analysis of the 1997-2014 NHIS-NDI Record Linkage Study

  2021cites this paper
• Revisiting medication: listening to lived experiences from persons in mental health recovery without ongoing medication use

  2020cites this paper
• History of Psychopharmacology.

  2019cites this paper
• Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015

  2018cites this paper
• Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing

  2018cites this paper
• The 21st century psychiatrists need to reestablish their identity as healers of the human psyche and not just pill pushers

  2016cites this paper
• Pharmacogenetic Testing

  2016cites this paper